Predictive value of BubR1 and synuclein- gamma expression in breast cancer.

被引:0
|
作者
Cirak, Yalcin
Furuncuoglu, Yavuz
Yapicier, Ozlem
Argon, Andac
Alici, Suleyman
机构
[1] Bahcesehir Univ, Sch Med, Div Med Oncol, Istanbul, Turkey
[2] Goztepe Med Pk Hosp, Istanbul, Turkey
[3] Bahcesehir Univ, Sch Med, Div Pathol, Istanbul, Turkey
关键词
D O I
10.1200/jco.2015.33.15_suppl.e13511
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13511
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Synuclein-gamma is overexpressed in pancreatic cancer.
    Li, ZK
    Chiao, PJ
    Evans, DB
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1199S - 1199S
  • [32] Prognostic and predictive value of PDL1 expression in breast cancer
    Sabatier, Renaud
    Finetti, Pascal
    Mamessier, Emilie
    Adelaide, Jose
    Chaffanet, Max
    Ali, Hamid Raza
    Viens, Patrice
    Caldas, Carlos
    Birnbaum, Daniel
    Bertucci, Francois
    ONCOTARGET, 2015, 6 (07) : 5449 - 5464
  • [33] Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients
    Min, Li
    Zhang, Cheng
    Ma, Ruolan
    Li, Xiaofan
    Yuan, Hua
    Li, Yihao
    Chen, Ruxuan
    Liu, Caiyun
    Guo, Jianping
    Qu, Like
    Shou, Chengchao
    BMC CANCER, 2016, 16
  • [34] Elevated BUBR1 Expression Is Associated with Poor Survival in Early Breast Cancer Patients: 15-Year Follow-up Analysis
    Maciejczyk, Adam
    Szelachowska, Jolanta
    Czapiga, Bogdan
    Matkowski, Rafal
    Halon, Agnieszka
    Gyoerffy, Balazs
    Surowiak, Pawel
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2013, 61 (05) : 330 - 339
  • [35] Downregulation of BUBR1 regulates the proliferation and cell cycle of breast cancer cells and increases the sensitivity of cells to cisplatin
    Lu, Yiran
    Wang, Ruiqing
    He, Song
    Zhang, Qing
    Wei, Jiahui
    Hu, Jinping
    Ding, Yu
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2023, 59 (10) : 778 - 789
  • [36] Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients
    Li Min
    Cheng Zhang
    Ruolan Ma
    Xiaofan Li
    Hua Yuan
    Yihao Li
    Ruxuan Chen
    Caiyun Liu
    Jianping Guo
    Like Qu
    Chengchao Shou
    BMC Cancer, 16
  • [37] Predictive value of heparanase expression in the palliative therapy of pancreatic cancer.
    Caca, K
    Kronberg, J
    Tannapfel, A
    Wittekind, C
    Moessner, J
    Schoppmeyer, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 855S - 855S
  • [38] BubR1 alterations that reinforce mitotic surveillance act against aneuploidy and cancer
    Weaver, Robbyn L.
    Limzerwala, Jazeel F.
    Naylor, Ryan M.
    Jeganathan, Karthik B.
    Baker, Darren J.
    van Deursen, Jan M.
    ELIFE, 2016, 5
  • [39] Clinicopathologic significance of BubR1 and Mad2 overexpression in oral cancer
    Teixeira, J. H.
    Silva, P. M. A.
    Faria, J.
    Ferreira, I.
    Duarte, P.
    Delgado, M. L.
    Queiros, O.
    Moreira, R.
    Barbosa, J.
    Lopes, C. A.
    do Amaral, J. S.
    Monteiro, L. S.
    Bousbaa, H.
    ORAL DISEASES, 2015, 21 (06) : 713 - 720
  • [40] Predictive value of immunocytochemical detection of breast cancer cells and other factors in autotransplantation for breast cancer.
    Penza, SL
    Avalos, BR
    Elder, PJ
    Fike, S
    Farag, SS
    Marcucci, G
    O'Donnell, LC
    Scholl, MD
    Whittaker, B
    Mrozek, E
    Bechtel, TP
    Copelan, EA
    BLOOD, 2000, 96 (11) : 424A - 424A